Wednesday, 3 August 2022

PvPI reveals new adverse drug reaction of Tacrolimus

PvPI reveals new adverse drug reaction of Tacrolimus
PvPI reveals new adverse drug reaction of Tacrolimus

The preliminary analysis of Adverse Drug Reaction (ADR) from the PvPI database reveals that Tacrolimus is associated with Gingival Hypertrophy.

admin Wed, 08/03/2022 - 14:45

source https://www.pharmatutor.org/pharma-news/2022/pvpi-reveals-new-adverse-drug-reaction-of-tacrolimus

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...